Skip to main content
Clinical Trials/NL-OMON28560
NL-OMON28560
Recruiting
Not Applicable

THE MUSCLE POWER STUDY: Surgery related muscle loss and muscle strength after complex abdominal surgery for pseudomyxoma peritonei, pancreatic, liver and colorectal cancer

This work is supported by a grant from the UMCG Cancer Research Foundation (Institutional Foundation for Cancer Research and Development). The study protocol has not undergone any peer-review by this funding body, nor will they play a role in the analysis and interpretation of the data.0 sites178 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
• pseudomyxoma peritonei (PMP)• liver tumor (primary cancer or colorectal liver metastases)• pancreatic cancer• bile duct cancer • colorectal cancer
Sponsor
This work is supported by a grant from the UMCG Cancer Research Foundation (Institutional Foundation for Cancer Research and Development). The study protocol has not undergone any peer-review by this funding body, nor will they play a role in the analysis and interpretation of the data.
Enrollment
178
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
This work is supported by a grant from the UMCG Cancer Research Foundation (Institutional Foundation for Cancer Research and Development). The study protocol has not undergone any peer-review by this funding body, nor will they play a role in the analysis and interpretation of the data.

Eligibility Criteria

Inclusion Criteria

  • In order to be eligible to participate in this study, a patient must meet all of the following inclusion criteria:
  • Age \= 18 years;
  • Able to read and understand the Dutch language;
  • Diagnosed or the suspicion of a liver tumor (primary cancer or colorectal liver metastases), pancreatic malignancy, bile duct malignancy, colon tumor, rectum tumor, or pseudomyxoma peritonei;
  • Scheduled to undergo elective open major abdominal surgery at UMCG, consisting of the following surgical procedures:
  • ocytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy (CRS with HIPEC);
  • o(sub)total pelvic exenteration;
  • opylorus preserving pancreaticoduodenectomy (PPPD);
  • owhipple procedure (classic pancreaticoduodenectomy);
  • o(sub)total pancreatectomy; or

Exclusion Criteria

  • A potential eligible patient who meets any of the following exclusion criteria will be excluded from participation in this study:
  • Scheduled to undergo emergency resection;
  • Scheduled to undergo laparoscopic surgery;
  • Scheduled to undergo minor liver resections (defined as \<3 liver segments);
  • Inability to co\-operate and give informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials